In the fourteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the recent data on COVID-19 and children. This presentation will cover the typical presentation of COVID-19 in children and review the risk and mechanisms of Multisystem Inflammatory Syndrome in Children (MIS-C). 

Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 07/21/2020 and they are subject to change as new information is published.


Learning Objectives

  • Assess the typical presentation of COVID-19 among children
  • Evaluate the risk of multisystem inflammatory syndrome among children (MIS-C) with COVID-19
  • Describe the purported mechanisms for MIS-C and how it should be classified, evaluated and treated

  • Faculty

    Ty J. Gluckman, MD, FACC, FAHA

    Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health
    Portland, OR 

    Charles Vega, MD, FAAFP

    Health Sciences Clinical Professor
    UC Irvine Department of Family Medicine
    Assistant Dean for Culture and Community Education
    Executive Director, UC Irvine Program in Medical Education for the Latino Community
    UC Irvine School of Medicine
    Irvine, CA 


    The following relevant financial relationships have been disclosed by faculty: 

    Ty J. Gluckman, MD, FACC, FAHA

    Has disclosed no relevant financial relationships. 

    Charles Vega, MD, FAAFP

    Has disclosed no relevant financial relationships. 


    Non-faculty contributors involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.

    CME/CE Information

    AMA PRA Category 1 Credits

    Accreditation Statement

    Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Designation Statement

    Pri-Med Institute designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Commercial Supporter

    Not Applicable

    Education Partner

    Not Applicable

    Fine Print

    The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

    The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

    Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

    Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

    Pri-Med Institute Accredited Provider
    Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

    Disclosures and Conflict of Interest
    Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

    Discussion of Off-Label Uses and Investigational Products
    During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

    Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.